AUPH Stock: Price, Earnings History and SEC Filings
Aurinia Pharmaceuticals Inc. (AUPH) last traded at $16.65, down 3.25% on the latest session and up 2.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.28 against an analyst estimate of $0.18, a beat of 55.6%.
$16.65 -3.25%
1 month+2.81%
52-week high$19.25
52-week low$12.79
Volume960,843
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AUPH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.28 | $0.18 | +55.56% |
| Mar 2026 | May 7, 2026 | $0.25 | $0.18 | +38.89% |
| Dec 2025 | Feb 26, 2026 | $0.26 | $0.21 | +23.81% |
| Sep 2025 | Nov 4, 2025 | $0.23 | $0.16 | +43.75% |
AUPH beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for AUPH
SEC filing data is not available right now. You can search for AUPH on SEC EDGAR.
AUPH news
- Aurinia Pharmaceuticals (AUPH) Tops Q3 Earnings EstimatesOct 30, 2026 · finance.yahoo.com
- Aurinia: Q3 Earnings SnapshotOct 30, 2026 · finance.yahoo.com
- Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business ProgressOct 30, 2026 · finance.yahoo.com
- Earnings Preview: Ionis Pharmaceuticals (IONS) Q3 Earnings Expected to DeclineOct 28, 2026 · finance.yahoo.com
- Earnings Preview: Aurinia Pharmaceuticals (AUPH) Q3 Earnings Expected to DeclineOct 27, 2026 · finance.yahoo.com
About Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. (AUPH) is a US-listed public company on Nasdaq.